BRIEF-Intercept pharmaceuticals says a journal published results of Phase 3 poise trial of Ocaliva
August 17, 2016 at 17:19 PM EDT
* New England Journal Of Medicine publishes results of Phase 3 poise trial of ocaliva for treatment of PBC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.